Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros Grivas from Fred Hutchinson Cancer Center and Dr. Sumanta (Monty) Pal from City ... Show More
Nov 5
Ep. 341 Understanding Overactive Bladder in Male Patients with Dr. Bilal Chughtai
How many prostate medications and procedures should a man try before anyone checks his bladder? Dr. Bilal Chughtai has met men who worked through an alpha blocker, add-on medications, a minimally invasive prostate procedure, and even resective surgery before anyone named overacti ... Show More
40m 42s
Nov 3
Ep. 340 Understanding Intermediate-Risk Bladder Cancer with Dr. Wesley Yip
By one estimate, half or more of all non-muscle invasive bladder cancer (NMIBC) is intermediate risk, yet the major guidelines still do not define it the same way, which leaves urologists sorting a large, mixed group of patients without a shared playbook for when to resect again, ... Show More
43m 42s
Oct 29
Ep. 339 AI's Role in Enhancing Urology Care with Dr. David Canes
By his own estimate, an AI scribe gives one urologist about two hours of his day back, and an evidence tool built into it has taught him something new in the clinic almost every day. On this episode of BackTable Urology, Dr. Ruchika Talwar welcomes back Dr. David Canes, urologist ... Show More
58m 27s
Feb 2024
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
<p>Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influen ... Show More
30m 6s
Mar 2024
Episode 171: ASCO-GU Top Clinical Data With Pedro Barata
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ... Show More
46m 7s
Dec 2023
UROONCO RCC take home message for 2023
<p>In this podcast, UROONCO RCC board members, chief editor Dr. Carmen Mir (ES), and associate editors Dr. Riccardo Bertolo (IT) and Dr. Teele Kuusk (GB), discuss the progress made in the field of kidney cancer during 2023, and what is anticipated for 2024.<br/><br/>Some topics d ... Show More
18m 27s
Feb 2024
Advances in Precision Oncology for GI Cancers at GI24
<p class="MsoNormal"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Shaalan Beg and Rachna Shroff discuss key abstracts on GI cancers that were featured at the 2024 ASCO Gastrointestinal Cancers Symposium, including SKYSCRAPER-08, EMERALD-1, and N ... Show More
22m 45s
<p class="MsoNormal" style="text-align: justify;"><span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ... Show More
